The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
FOLFIRI versus irinotecan monodrug as second-line treatment in metastatic colorectal cancer patients: An open, multicenter, prospective, randomized controlled phase III clinical study.
 
Weijian Guo
No Relationships to Disclose
 
Xiaowei Zhang
No Relationships to Disclose
 
Yusheng Wang
No Relationships to Disclose
 
Wen Zhang
No Relationships to Disclose
 
Xin Liu
No Relationships to Disclose
 
Wei Shen
No Relationships to Disclose
 
Yifu He
No Relationships to Disclose
 
Xiaodong Zhu
No Relationships to Disclose
 
Zhiyu Chen
No Relationships to Disclose
 
Hong Qiang Wang
No Relationships to Disclose
 
Mingzhu Huang
No Relationships to Disclose
 
Zhe Zhang
No Relationships to Disclose
 
Xiaoying Zhao
No Relationships to Disclose
 
Lixin Qiu
No Relationships to Disclose
 
Chenchen Wang
No Relationships to Disclose
 
Xuedan Sheng
No Relationships to Disclose